Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;28(6):411-8.
doi: 10.1007/s10719-011-9340-7. Epub 2011 Jul 9.

Inhibition of Helicobacter pylori adhesion to Kato III cells by intact and low molecular weight acharan sulfate

Affiliations

Inhibition of Helicobacter pylori adhesion to Kato III cells by intact and low molecular weight acharan sulfate

Joon-Soo Sim et al. Glycoconj J. 2011 Aug.

Abstract

We investigated the inhibitory activity of glycosaminoglycans (GAGs) in terms of growth, adhesion, and VacA vacuolation of Helicobacter pylori. Intact acharan sulfate (AS, MW:114 kDa) potently inhibited H. pylori adhesion to Kato III cells with IC(50) value of 1.4 mg/mL, while other GAGs did not show any inhibitory activity except for heparin which is a well-known inhibitor of H. pylori adhesion. To investigate whether low molecular weight acharan sulfate (LMWAS) can inhibit H. pylori adhesion, we performed chemical depolymerization of AS by radical reactions to obtain LMWAS. Its physicochemical properties were characterized by high-performance size exclusion chromatography (HPSEC), agarose gel electrophoresis, disaccharide compositional analysis after digestion with heparinase II, and (1)H-NMR spectroscopy. The most potent molecular size of LMWAS was 3 kDa with IC(50) value of 32 μg/mL, which is 44-fold more potent than intact AS. These results suggest that AS as well as other GAGs can be chemically depolymerized by free radicals and LMWAS compared to intact AS can be applied as a pharmaceutical candidate in order to inhibit H. pylori adhesion to Kato III cells.

PubMed Disclaimer

References

    1. Infect Immun. 1996 Feb;64(2):624-8 - PubMed
    1. J Chromatogr. 1993 Dec 8;622(1):13-20 - PubMed
    1. Lancet. 1993 Aug 28;342(8870):507-8 - PubMed
    1. J Med Microbiol. 1997 Jul;46(7):541-6 - PubMed
    1. J Cell Biochem. 2010 Aug 1;110(5):1272-8 - PubMed

Publication types

LinkOut - more resources